Robin Stevenson
Directeur/Membre du Conseil chez Avelas Biosciences, Inc.
Postes actifs de Robin Stevenson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Directeur/Membre du Conseil | 18/10/2021 | - |
Historique de carrière de Robin Stevenson
Anciens postes connus de Robin Stevenson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
The Breast Cancer Research Trust
 The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
| Nouvelle-Zélande | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 2 |
Sectorielle
| Health Technology | 2 |
| Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The Breast Cancer Research Trust
The Breast Cancer Research Trust Medical SpecialtiesHealth Technology The Breast Cancer Research Trust operates as not-for profit organization. It provides breast cancer treatment solutions. The company was founded in 1997 and is headquartered in Auckland, New Zealand. | Health Technology |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
- Bourse
- Insiders
- Robin Stevenson
- Expérience
